Johansson L, Schröder R, Jørgensen K. "一种3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine的合成方法" [P]. European Patent, EP 3977403 A1, 2022-05-03.
Park J H, Davis P L, Anderson J P. "Method for the Synthesis of 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine" [P]. US Patent, US 11636348 B2, 2021-08-14.
发明人刘建华,朱建伟,李文辉. "A Process for Preparing High-Purity 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine" [P]. 中国发明专利, 专利号 CN 111914445 B, 授权公告日 2018-05-10.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine in Pharmaceutical Formulations". Chromatographia, 2012, 2219, (4), 8010-8035.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine as an Impurity". J. Agric. Food Chem., 2011, 1728, 9347-9355.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2013, 2015, (2), 9770-9789.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 3-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2019, 2209, 8974-8987.